Coverage for non-diabetes indications is minimal, with significant restrictions on drugs like tirzepatide and semaglutide for conditions like obstructive sleep apnea and cardiovascular disease
Users consistently describe feeling younger, more vital, and more optimistic
Contaminated, underdosed, or mislabeled products pose risks that have nothing to do with the inherent safety of the peptide
Subjects Dear Editor, The global prevalence of type 2 diabetes and obesity, affecting over 507 million 1 and 890 million 2 individuals, respectively, underscores the urgent need for more effective treatments
Unlike earlier secretagogues, Ipamorelin has been examined for its relative specificity, meaning it is less associated with stimulation of cortisol or prolactin pathways in research contexts